Alma Osmanovic - Concepedia

Author

Alma Osmanovic

Medizinische Hochschule Hannover ORCID

Also Known As

A Osmanovic, A. Osmanovic, Alma Osmanovic, Anastasia Sarikidi, Benedikt Winter, Bernd Wilken

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Medizinische Hochschule Hannover Universität Ulm Essen University Hospital German Center for Neurodegenerative Diseases University of Rostock

About

Alma Osmanovic is an author at Medizinische Hochschule Hannover specializing in medicine, neurology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	307
2	Health Sciences	2	2	33
3	Natural Sciences	2	2	72
4	Engineering	1	1	10
5	Public Health	1	1	10

Alma Osmanovic

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study Tim Hagenacker, Claudia D. Wurster, René Günther, The Lancet Neurology	2020	345
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial Albert C. Ludolph, Joachim Schuster, Johannes Dorst, The Lancet Neurology Amyotrophic Lateral SclerosisNeurological DisorderMedicineClinical TrialsPharmacotherapy	2018	78
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen Thomas Meyer, André Maier, Željko Uzelac, European Journal of Neurology	2021	63
FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study Alma Osmanovic, I Rangnau, Anne Kosfeld, European Journal of Human Genetics Neurodegenerative DiseasesAmyotrophic Lateral SclerosisMedicineGeneticsNeurology	2017	60
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment Maren Freigang, Claudia D. Wurster, Tim Hagenacker, Annals of Clinical and Translational Neurology	2021	59
Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers’ Lives Pavel Schischlevskij, Isabell Cordts, René Günther, Brain Sciences	2021	59
Identification and functional analysis of novel THAP1 mutations Katja Lohmann, Nils Uflacker, Alev Erogullari, European Journal of Human Genetics Genome InstabilityNatural SciencesNovel Thap1 MutationsSignal RecognitionDna Replication	2011	54
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study René Günther, Claudia D. Wurster, Svenja Brakemeier, The Lancet Regional Health - Europe	2024	54
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy Alma Osmanovic, Gresa Ranxha, Mareike Kumpe, Journal of Neurology	2020	52
Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group Kristin Diekmann, Magdalena Kuźma‐Kozakiewicz, Maria Piotrkiewicz, Journal of Neurology Amyotrophic Lateral SclerosisDisease ProgressionNeurological DisorderDisease OnsetNeurology	2020	43

Page 1